v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash flows from operating activities:    
Net income $ 994 $ 31,951
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 91,187 92,137
Equity in income of joint ventures (5,994) (7,101)
Stock-based compensation expense 15,554 14,282
Elimination of unrealized loss on sales to joint ventures 260 0
Deferred taxes (4,360) (16,049)
Unrealized foreign exchange loss (gain) 3,127 (6,047)
Changes in assets and liabilities:    
Accounts receivable, net (1,995) 15,118
Inventories (2,691) (9,020)
Other assets (11,921) (11,557)
Accounts payable and accrued liabilities 34,852 (17,289)
Other liabilities (4,614) 12,931
Income taxes, net (8,042) (6,599)
Dividends received from joint ventures 4,662 498
Other (4,273) (3,333)
Net cash provided by operating activities 106,746 89,922
Cash flows from investing activities:    
Capital expenditures (56,948) (54,316)
Proceeds from disposal of assets 0 5,000
Net cash used in investing activities (56,948) (49,316)
Cash flows from financing activities:    
Release of (cash pledged for) collateral deposits, net 113 (415)
Proceeds from borrowings 1,794 0
Repurchase of common stock (39,998) (15,033)
Payment of withholding taxes on stock-based compensation plans (5,003) (2,588)
Repayment of financed insurance premium (526) (4,955)
Repayments of finance leases (1,525) (887)
Net cash used in financing activities (45,145) (23,878)
Effect of exchange rate changes on cash and cash equivalents (2,560) 6,095
Net increase to cash and cash equivalents and restricted cash 2,093 22,823
Cash and cash equivalents and restricted cash at beginning of period 197,473 184,663
Cash and cash equivalents and restricted cash at end of period $ 199,566 $ 207,486